Atlas Trials

EGFR Unknown or Wild-type

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch EGFR Unknown or Wild-type

RecordFirmDate
A Phase I/II Study of Tivozanib and Erlotinib as Initial Treatment for Metastatic Non-small Cell Lung Cancer Assigned by VeriStrat® Serum Proteomic Evaluation (NCT01728181)University of Utah2013-11-01

Track EGFR Unknown or Wild-type automatically

Every clearance here is in the API, with alerts when new ones post.